-
1دورية أكاديمية
المؤلفون: Feldman, Gregory J., Sousa, Ana R., Lipson, David A., Tombs, Lee, Barnes, Neil, Riley, John H., Patel, Sadhana, Naya, Ian, Compton, Chris, Alcazar Navarrete, Bernardino
المساهمون: Feldman, Gregory J. S Carolina Pharmaceut Res, Spartanburg, SC 29303 USA, Sousa, Ana R. GlaxoSmithKline, Resp Res & Dev, Stockley Pk West, Uxbridge, Middx, England, Lipson, David A. GlaxoSmithKline, Resp Res & Dev, King Of Prussia, PA USA, Lipson, David A. Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA, Tombs, Lee Precise Approach Ltd, Birmingham, W Midlands, England, Barnes, Neil GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, Patel, Sadhana GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, Compton, Chris GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, Riley, John H. GlaxoSmithKline, GlaxoSmithKline Med Res Ctr, Resp Therapy Area Unit, Stevenage, Herts, England, Naya, Ian GlaxoSmithKline, Resp Med, Brentford, Middx, England, Alcazar Navarrete, Bernardino Hosp Alta Resoluc Loja, Neumol, Granada, Spain, GlaxoSmithKline
مصطلحات موضوعية: Bronchodilation, COPD, LAMA, LABA, Long-acting muscarinic antagonist, Long-acting beta 2-agonist, Olodaterol, Tiotropium, Umeclidinium, Vilanterol, Dynamic hyperinflation, Double-blind, Safety, Bronchodilators, Combination, Moderate
العلاقة: http://hdl.handle.net/10668/18661Test; https://link.springer.com/content/pdf/10.1007/s12325-017-0626-4.pdfTest; 416262300010
-
2
المؤلفون: John H. Riley, Ian Naya, Neil Barnes, Lee Tombs, Ana R. Sousa, Bernardino Alcázar Navarrete, Sadhana Patel, Gregory J. Feldman, David A. Lipson, Chris Compton
المساهمون: [Feldman, Gregory J.] S Carolina Pharmaceut Res, Spartanburg, SC 29303 USA, [Sousa, Ana R.] GlaxoSmithKline, Resp Res & Dev, Stockley Pk West, Uxbridge, Middx, England, [Lipson, David A.] GlaxoSmithKline, Resp Res & Dev, King Of Prussia, PA USA, [Lipson, David A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA, [Tombs, Lee] Precise Approach Ltd, Birmingham, W Midlands, England, [Barnes, Neil] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Patel, Sadhana] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Compton, Chris] GlaxoSmithKline, Global Resp Franchise, Brentford, Middx, England, [Riley, John H.] GlaxoSmithKline, GlaxoSmithKline Med Res Ctr, Resp Therapy Area Unit, Stevenage, Herts, England, [Naya, Ian] GlaxoSmithKline, Resp Med, Brentford, Middx, England, [Alcazar Navarrete, Bernardino] Hosp Alta Resoluc Loja, Neumol, Granada, Spain, GlaxoSmithKline
المصدر: Advances in Therapy
مصطلحات موضوعية: Male, Quinuclidines, Respimat, Long-acting β2-agonist, law.invention, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Forced Expiratory Volume, Medicine, Pharmacology (medical), Vilanterol, 030212 general & internal medicine, Original Research, education.field_of_study, COPD, Cross-Over Studies, Olodaterol, LAMA, Double-blind, General Medicine, Middle Aged, Dry-powder inhaler, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Anesthesia, Combination, Long-acting beta 2-agonist, Female, Bronchodilation, Safety, Moderate, Population, LABA, Chlorobenzenes, 03 medical and health sciences, Bronchodilators, Double-Blind Method, Administration, Inhalation, Humans, Umeclidinium, Tiotropium Bromide, education, Benzyl Alcohols, Dynamic hyperinflation, Aged, business.industry, Nebulizers and Vaporizers, Tiotropium, medicine.disease, Confidence interval, Benzoxazines, Long-acting muscarinic antagonist, 030228 respiratory system, chemistry, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa4d2adec229bf9ad2d05d732898175Test
https://doi.org/10.1007/s12325-017-0626-4Test